• Innovating Randomization and Trial Supply Management

    Clinical Informatics News | The goal of clinical trials is to develop and market superior therapies with maximum efficiency at minimum cost. But doing so depends upon the ability to successfully complete every trial step with nuanced behind-the-scenes timing, skill, and precision. These rarely-noticed mundane, yet critical technological processes are taken for granted but are an integral part of today’s pharma landscape.

    Jul 28, 2016

  • FluGen Starts Clinical Trial for Universal Flu Vaccine

    Xconomy |  It took longer than FluGen planned, but a human clinical trial is now underway for the experimental universal influenza vaccine that the Madison, WI-based biotech startup is developing.

    Jul 28, 2016

  • Microsoft’s Iowa data center cluster to reach 3.2M square feet

    Computerworld |  Microsoft is creating some 3.2 million square feet of data center space in the West Des Moines, Iowa, area but in three separate locations. The combined investment is about $3.5 billion.

    Jul 28, 2016

  • Well-known hospitals fail to get 5 stars in new Medicare ratings

    STAT |  The government released its first overall hospital quality rating, slapping average or below average scores on many of the nation's best-known hospitals.

    Jul 27, 2016

  • Warning Government Listing Of Clinical Trials Doesn’t Disclose Costs To Patients

    Kaiser Health News |  Some clinics on NIH's website charge people to participate in testing of unproven treatments - and it can come as a surprise to unsuspecting patients.

    Jul 27, 2016

  • Promising Alzheimers Treatment Flops in New Trial

    STAT |  A treatment for Alzheimer's remains elusive, despite decades of work and hundreds of millions in investment. The latest drug to fail is from biotech TauRx.

    Jul 27, 2016

  • FDA Finalizes Guidance on Adaptive Designs for Device Studies

    RAPS |  The US Food and Drug Administration (FDA) on Tuesday finalized guidance that lays out how to design medical device clinical trials that allow for changes based on data, while maintaining study validity and integrity.

    Jul 26, 2016

  • CDOs and Data Science's Evolving Role in Healthcare and Life Science

    Clinical Informatics News | CAMBRIDGE, Mass.—Want to succeed in the healthcare or life-sciences sector as a top-tier, influential executive in the world of big data and analytics?  Top experts convening at the Massachusetts Institute of Technology this month advised that, among other things, the key lies in fostering a collaborative corporate culture and working well with others.

    Jul 25, 2016

  • Chinese scientists to pioneer first human CRISPR trial

    Nature News & Comment |  Gene-editing technique to treat lung cancer is due to be tested in people in August. Sichuan University's West China Hospital in Chengdu plans to inject lung cancer patients with cells modified using the CRISPR-Cas9 gene-editing technique. The clinical trial received ethical approval from the hospital July 6.

    Jul 22, 2016

  • Computationally Predicting Drug Combos

    Clinical Informatics News  The urgency to find treatment for his ailing father inspired an MIT professor to develop a method to successfully predict cancer therapy outcomes, replacing intuition with data, potentially saving millions of dollars, and extending patients’ lives up to six months.

    Jul 21, 2016

  • NIH Policy Calls for Multi-Site Research to Use a Single IRB

    Clinical Informatics News | The National Institutes of Health (NIH) has issued a new policy stating that all NIH-sponsored multi-site research protocols within U.S. jurisdiction must use a single Institutional Review Board  across all sites.

    Jul 18, 2016

  • JAX, AMA, Scripps Launch Genomic Education for Physicians

    Clinical Informatics News | The American Medical Association (AMA), in partnership with Scripps Translational Science Institute (Scripps) and The Jackson Laboratory (JAX), have announced a new online program aimed at educating physicians and other health care professionals on the benefits and limitations of genetic testing and when it is appropriate to incorporate it into their practices.

    Jul 14, 2016

  • Juno Therapeutics Re-Starts Cancer Trial After Deaths Put Study on Hold

    Forbes |  Juno Therapeutics has been given the green light to re-start a cancer clinical trial less than a week after regulators put it on hold because of three patient deaths. The Seattle biotech company, a leader in the emerging field of engineered T-cell immunotherapy for cancer, said today the FDA has allowed it to start enrolling patients once again.

    Jul 13, 2016